当前位置: 首页 >> 检索结果
61. Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement.
作者: Brennan C Kahan.;Sophie S Hall.;Elaine M Beller.;Megan Birchenall.;An-Wen Chan.;Diana Elbourne.;Paul Little.;John Fletcher.;Robert M Golub.;Beatriz Goulao.;Sally Hopewell.;Nazrul Islam.;Merrick Zwarenstein.;Edmund Juszczak.;Alan A Montgomery.
来源: JAMA. 2023年330卷21期2106-2114页
Transparent reporting of randomized trials is essential to facilitate critical appraisal and interpretation of results. Factorial trials, in which 2 or more interventions are assessed in the same set of participants, have unique methodological considerations. However, reporting of factorial trials is suboptimal.
62. Obesity Management in Adults: A Review.
作者: Arielle Elmaleh-Sachs.;Jessica L Schwartz.;Carolyn T Bramante.;Jacinda M Nicklas.;Kimberly A Gudzune.;Melanie Jay.
来源: JAMA. 2023年330卷20期2000-2015页
Obesity affects approximately 42% of US adults and is associated with increased rates of type 2 diabetes, hypertension, cardiovascular disease, sleep disorders, osteoarthritis, and premature death.
63. Hepatitis D: A Review.
Hepatitis D virus (HDV) infection occurs in association with hepatitis B virus (HBV) infection and affects approximately 12 million to 72 million people worldwide. HDV causes more rapid progression to cirrhosis and higher rates of hepatocellular carcinoma than HBV alone or hepatitis C virus.
64. Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis.
作者: Melissa McPheeters.;Elizabeth A O'Connor.;Sean Riley.;Sara M Kennedy.;Christiane Voisin.;Kaitlin Kuznacic.;Cory P Coffey.;Mark D Edlund.;Georgiy Bobashev.;Daniel E Jonas.
来源: JAMA. 2023年330卷17期1653-1665页
Alcohol use disorder affects more than 28.3 million people in the United States and is associated with increased rates of morbidity and mortality.
65. Screening, Referral, Behavioral Counseling, and Preventive Interventions for Oral Health in Children and Adolescents Aged 5 to 17 Years: A Systematic Review for the US Preventive Services Task Force.
作者: Roger Chou.;Christina Bougatsos.;Jessica Griffin.;Shelley S Selph.;Azrah Ahmed.;Rongwei Fu.;Chad Nix.;Eli Schwarz.
来源: JAMA. 2023年330卷17期1674-1686页
Dental caries is common in children and adolescents aged 5 to 17 years and potentially amenable to primary care screening and prevention.
66. Screening and Preventive Interventions for Oral Health in Children and Adolescents Aged 5 to 17 Years: US Preventive Services Task Force Recommendation Statement.
作者: .;Michael J Barry.;Wanda K Nicholson.;Michael Silverstein.;David Chelmow.;Tumaini Rucker Coker.;Esa M Davis.;Katrina E Donahue.;Carlos Roberto Jaén.;Li Li.;Gbenga Ogedegbe.;Lori Pbert.;Goutham Rao.;John M Ruiz.;James Stevermer.;Joel Tsevat.;Sandra Millon Underwood.;John B Wong.
来源: JAMA. 2023年330卷17期1666-1673页
Oral health is fundamental to health and well-being across the lifespan. Oral health conditions affect the daily lives of school-age children and adolescents, leading to loss of more than 51 million school hours every year. Untreated oral health conditions in children can lead to serious infections and affect growth, development, and quality of life.
67. Evaluation and Treatment of Knee Pain: A Review.
作者: Vicky Duong.;Win Min Oo.;Changhai Ding.;Adam G Culvenor.;David J Hunter.
来源: JAMA. 2023年330卷16期1568-1580页
Approximately 5% of all primary care visits in adults are related to knee pain. Osteoarthritis (OA), patellofemoral pain, and meniscal tears are among the most common causes of knee pain.
68. Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
作者: Stephen P Juraschek.;Jiun-Ruey Hu.;Jennifer L Cluett.;Anthony M Ishak.;Carol Mita.;Lewis A Lipsitz.;Lawrence J Appel.;Nigel S Beckett.;Ruth L Coleman.;William C Cushman.;Barry R Davis.;Greg Grandits.;Rury R Holman.;Edgar R Miller.;Ruth Peters.;Jan A Staessen.;Addison A Taylor.;Lutgarde Thijs.;Jackson T Wright.;Kenneth J Mukamal.
来源: JAMA. 2023年330卷15期1459-1471页
There are ongoing concerns about the benefits of intensive vs standard blood pressure (BP) treatment among adults with orthostatic hypotension or standing hypotension.
69. Hyperthyroidism: A Review.
Overt hyperthyroidism, defined as suppressed thyrotropin (previously thyroid-stimulating hormone) and high concentration of triiodothyronine (T3) and/or free thyroxine (FT4), affects approximately 0.2% to 1.4% of people worldwide. Subclinical hyperthyroidism, defined as low concentrations of thyrotropin and normal concentrations of T3 and FT4, affects approximately 0.7% to 1.4% of people worldwide. Untreated hyperthyroidism can cause cardiac arrhythmias, heart failure, osteoporosis, and adverse pregnancy outcomes. It may lead to unintentional weight loss and is associated with increased mortality.
70. Diagnosis and Treatment of Bipolar Disorder: A Review.
作者: Andrew A Nierenberg.;Bruno Agustini.;Ole Köhler-Forsberg.;Cristina Cusin.;Douglas Katz.;Louisa G Sylvia.;Amy Peters.;Michael Berk.
来源: JAMA. 2023年330卷14期1370-1380页
Bipolar disorder affects approximately 8 million adults in the US and approximately 40 million individuals worldwide.
71. Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis.
作者: Manuel Sánchez-de-la-Torre.;Esther Gracia-Lavedan.;Ivan D Benitez.;Alicia Sánchez-de-la-Torre.;Anna Moncusí-Moix.;Gerard Torres.;Kelly Loffler.;Richard Woodman.;Robert Adams.;Gonzalo Labarca.;Jorge Dreyse.;Christine Eulenburg.;Erik Thunström.;Helena Glantz.;Yüksel Peker.;Craig Anderson.;Doug McEvoy.;Ferran Barbé.
来源: JAMA. 2023年330卷13期1255-1265页
The effect of continuous positive airway pressure (CPAP) on secondary cardiovascular disease prevention is highly debated.
72. Clinical Care for People Who Survive Childhood Cancer: A Review.
An estimated 15 000 children and adolescents aged 0 to 19 years are diagnosed with cancer each year in the US, and more than 85% survive for at least 5 years. By 45 years of age, approximately 95% of people who survive childhood cancer will develop a significant health problem related to the childhood cancer diagnosis or its treatment.
73. Screening for Hypertensive Disorders of Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
作者: Jillian T Henderson.;Elizabeth M Webber.;Rachel G Thomas.;Kimberly K Vesco.
来源: JAMA. 2023年330卷11期1083-1091页
Hypertensive disorders of pregnancy are a leading cause of pregnancy-related morbidity and mortality in the US.
74. Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement.
作者: .;Michael J Barry.;Wanda K Nicholson.;Michael Silverstein.;Michael D Cabana.;David Chelmow.;Tumaini Rucker Coker.;Esa M Davis.;Katrina E Donahue.;Carlos Roberto Jaén.;Li Li.;Gbenga Ogedegbe.;Goutham Rao.;John M Ruiz.;James Stevermer.;Joel Tsevat.;Sandra Millon Underwood.;John B Wong.
来源: JAMA. 2023年330卷11期1074-1082页
Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10 000 deliveries in 1993 to 1021 cases per 10 000 deliveries in 2016 to 2017.
75. Ulcerative Colitis in Adults: A Review.
Ulcerative colitis (UC) is a chronic inflammatory condition of the colon, with a prevalence exceeding 400 per 100 000 in North America. Individuals with UC have a lower life expectancy and are at increased risk for colectomy and colorectal cancer.
76. Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic Cough: A Systematic Review and Dose-Response Meta-Analysis.
作者: Elena Kum.;Matthew Patel.;Nermin Diab.;Mustafaa Wahab.;Dena Zeraatkar.;Derek K Chu.;Paul M O'Byrne.;Gordon H Guyatt.;Imran Satia.
来源: JAMA. 2023年330卷14期1359-1369页
Gefapixant represents an emerging therapy for patients with refractory or unexplained chronic cough.
77. Preexposure Prophylaxis for the Prevention of HIV: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
作者: Roger Chou.;Hunter Spencer.;Christina Bougatsos.;Ian Blazina.;Azrah Ahmed.;Shelley Selph.
来源: JAMA. 2023年330卷8期746-763页
A 2019 review for the US Preventive Services Task Force (USPSTF) found oral preexposure prophylaxis (PrEP) associated with decreased HIV infection risk vs placebo or no PrEP in adults at increased HIV acquisition risk. Newer PrEP regimens are available.
78. Cervical Cancer Screening: A Review.
作者: Rebecca B Perkins.;Nicolas Wentzensen.;Richard S Guido.;Mark Schiffman.
来源: JAMA. 2023年330卷6期547-558页
Each year in the US, approximately 100 000 people are treated for cervical precancer, 14 000 people are diagnosed with cervical cancer, and 4000 die of cervical cancer.
79. Folic Acid Supplementation to Prevent Neural Tube Defects: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
作者: Meera Viswanathan.;Rachel Peragallo Urrutia.;Kesha N Hudson.;Jennifer Cook Middleton.;Leila C Kahwati.
来源: JAMA. 2023年330卷5期460-466页
Neural tube defects are among the most common birth defects in the US.
80. Screening for Lipid Disorders in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
作者: Janelle M Guirguis-Blake.;Corinne V Evans.;Erin L Coppola.;Nadia Redmond.;Leslie A Perdue.
来源: JAMA. 2023年330卷3期261-274页
Lipid screening in childhood and adolescence can lead to early dyslipidemia diagnosis. The long-term benefits of lipid screening and subsequent treatment in this population are uncertain.
|